ASK REDCHAT ANYTHING ABOUT DERMATA THERAPEUTICS INC.
Dermata Therapeutics Inc. (NASDAQ: DRMA)
Listen to this Section
$1.20
-0.0500
(
-4.00% )
37.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| DMT310DetailsAcne vulgaris, Acne |
Phase 3 |
| DMT310DetailsPsoriasis |
Failed |
| DMT310DetailsPapulopustular rosacea |
Failed |
Market Data
|
| Open |
$1.20 |
| Previous Close |
$1.25 |
| Volume |
37.0K |
| Market Cap |
$5.11M |
| Day Range |
$1.20 - $1.33 |
| 52 Week Range |
$1.10 - $8.00 |
| Shares Outstanding |
4.02M |
| Change % |
-4.00% |
| Net Change |
▼ -0.0500 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | Maxim Group LLC, Brookline Capital Markets, more |
Insider Ownership Transactions
Total Amount Purchased:
-320,000.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-01-05 |
Sale |
-25000.00 |
Bedoya-Toro Munera Maria E |
| 2024-01-05 |
Sale |
-125000.00 |
PROEHL GERALD T |
| 2024-01-05 |
Sale |
-10000.00 |
FISHER MARY |
| 2024-01-05 |
Sale |
-10000.00 |
Scott Kathleen D. |
| 2024-01-05 |
Sale |
-10000.00 |
Sandler Andrew Seth |
| 2024-01-05 |
Sale |
-50000.00 |
Nardo Christopher J. |
| 2024-01-05 |
Sale |
-10000.00 |
WIERENGA WENDELL |
| 2024-01-05 |
Sale |
-10000.00 |
HALE DAVID F |
| 2024-01-05 |
Sale |
-10000.00 |
Bradrick Brittany |
| 2024-01-05 |
Sale |
-50000.00 |
Van Hoose Kyri K. |